ADVERTISEMENT

More about this topic

weight loss

Now playing Next

Investors look to weight loss drugs to boost Novo Nordisk growth

TOP TAGS

EUROPEAN COMMISSION ARTIFICIAL INTELLIGENCE EU POLICY MUSIC URSULA VON DER LEYEN MARIO DRAGHI UNITED KINGDOM TOURISM

More about this topic

Now playing Next

Roche plans speedy weight-loss drug launch to catch up with rivals

Roche believes its anti-obesity drugs could have advantages over other more established rivals such as Eli Lilly and Novo Nordisk through ease of scalability that will allow it to meet increased demand.

30/07/2024

Now playing Next

Hundreds of Italian residents join their mayor on weight loss walks

A small Italian town mayor's fight to loss weight has gone viral after he campaigned for company on his weekly walks.

27/07/2024

Now playing Next

AstraZeneca tops second-quarter earnings forecasts and raises guidance

AstraZeneca exceeded market expectations in its second-quarter earnings report. The British pharmaceutical firm has also upgraded its guidance for fiscal year 2024.

25/07/2024

Now playing Next

Popular weight-loss drugs may be linked to blinding condition - study

Researchers identified a possible link between semaglutide and a rare eye condition but said more research is needed to know whether the drug actually caused the problem.

03/07/2024

ADVERTISEMENT

Now playing Next

Wegovy and Ozempic maker Novo Nordisk plans billion-dollar US plant

Novo Nordisk announces a plan to invest $4.1 billion to expand its capacity of making weight loss drug Wegovy and diabetes treatment Ozempic.

25/06/2024

Now playing Next

Global health authorities issue warning about fake Ozempic

A new global warning was issued over falsified versions of a popular weight-loss and type 2 diabetes drug.

21/06/2024

Now playing Next

'Ozempic breasts': What are the side effects of weight loss drugs?

While many people suffering from obesity have been using Ozempic to help with weight loss, health professionals are warning of potential side effects.

19/05/2024

Now playing Next

Ozempic found to cut heart disease and keep weight off for four years

New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular weight-loss drug.

14/05/2024

Now playing Next

Novo Nordisk beats Q1 estimates as weight-loss drugs drive growth

Danish pharmaceutical titan Novo Nordisk, the maker of Ozempic and Wegovy, announces a significant year-over-year increase in net profit and sales for the first quarter of 2024.

02/05/2024

Now playing Next

Fact-check: Will smoking keep you thin?

The worry of gaining weight is a common excuse for smokers not to quit. The Cube takes a look at a new study which found that both starting smoking and liftetime smoking may increase abdominal fat.

10/04/2024

Now playing Next

Novo Nordisk looks to expand into heart disease treatment

The Novo Nordisk deal is due to be wrapped up in the second quarter of this year. It will help to establish the maker of Wegovy and Ozempic in the cardiovascular treatment market.

26/03/2024

Now playing Next

Novo Nordisk expands lead on Tesla on upbeat obesity drug trial

Novo Nordisk, of anti-obesity drug Wegovy fame, reveals encouraging initial trial data for new weight loss drug that could potentially overtake Wegovy.

08/03/2024

Now playing Next

Drugmaker Novo Nordisk reaches market value of $500 million

Demand for obesity drugs has pushed Novo Nordisk's share price to new highs.

31/01/2024